Home

5-amino-1MQ is a synthetic small-molecule compound investigated for its ability to modulate the activity of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolic regulation and energy balance. NNMT plays a role in nicotinamide metabolism and influences the availability of nicotinamide adenine dinucleotide (NAD⁺), a central cofactor in mitochondrial function and cellular energy production. By inhibiting NNMT activity in experimental models, 5-amino-1MQ has been associated with increased NAD⁺ availability and modulation of metabolic signaling pathways, including those linked to sirtuin-1 (SIRT1). Preclinical research has explored its effects on energy utilization, adipose tissue metabolism, and metabolic efficiency without changes in caloric intake. This compound is primarily used as a research tool to investigate NNMT-related pathways and their role in metabolic regulation.

ACE-031 is a research compound employed in preclinical experimental systems to study myostatin pathway modulation and its involvement in skeletal muscle biology and tissue remodeling.

Advanced Follicular Activator is a structured multi-domain research formulation designed to address the complex biological architecture underlying follicular cycling dynamics. Rather than functioning as a single-pathway stimulant, the system integrates extracellular matrix stabilization, microvascular support, cytoskeletal adaptability, immune equilibrium modulation, and controlled Wnt/β-catenin pathway permissiveness. The primary formulation combines GHK-Cu, BPC-157 arginate, Thymosin Beta-4 fragment, Zinc–Thymulin, and PTD-DBM within a proprietary carrier system engineered for membrane interaction and controlled diffusion behavior. A secondary amplification module containing 1.5% Valproic Acid provides optional pathway reinforcement through GSK3β modulation and β-catenin stabilization under structured research conditions. This layered architecture is constructed to recalibrate the follicular microenvironment rather than impose isolated growth-factor mimicry or hormonal suppression. The formulation reflects a systems-based research model aligned with contemporary understanding of follicular signaling networks, structural integrity maintenance, and pathway permissiveness dynamics. FRESHLY PREPARED SOLUTION

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.

Adenosine monophosphate (AMP) has a well-known experimental analog in the molecule AICAR. In preclinical research models, AICAR has been extensively used to investigate AMPK-mediated cellular energy regulation, metabolic stress responses, and redox balance. In in vitro systems and animal studies, AICAR has been evaluated in experimental contexts related to cardiac ischemia models, where AMPK activation has been associated with modulation of cellular survival pathways under ischemic stress. Due to its role in regulating oxidative stress and energy metabolism, AICAR has also been studied in experimental ageing-related models, as well as in preclinical models of metabolic and inflammatory dysregulation, including those used to investigate mechanisms relevant to insulin signaling, immune activation, and chronic inflammation. These findings are limited to controlled laboratory and animal research settings and are used to explore underlying biological mechanisms rather than clinical applications.   FRESHLY PREPARED SOLUTION 

AOD9604 is a synthetic peptide derived from the C-terminal fragment (176–191) of human growth hormone (hGH), incorporating a disulfide bridge for structural stability. It is used in preclinical research models to investigate lipid metabolism, adipose tissue regulation, and related metabolic pathways, including experimental effects on lipolysis and lipogenesis. In animal and in vitro studies, AOD9604 has also been explored in research contexts involving metabolic, cardiometabolic, and musculoskeletal biology, including experimental models of bone and cartilage tissue remodeling, alone or in combination with other research peptides.  

ARA-290 has been investigated in preclinical and experimental research models designed to study inflammatory, metabolic, vascular, and neurobiological mechanisms relevant to the following disease-related research contexts: Cardiovascular-related experimental modelsRetinal ischemia and microvascular injury models Peripheral nerve injury and neuropathy models Small fiber nerve degeneration models Chronic inflammatory joint disease models Renal inflammation and metabolic stress models Hepatic lipid accumulation and inflammatory liver models Intestinal inflammation models Systemic autoimmune and immune dysregulation models Wound healing and tissue repair models  FRESHLY PREPARED SOLUTION 

ARA-290 has been investigated in preclinical and experimental research models designed to study inflammatory, metabolic, vascular, and neurobiological mechanisms relevant to the following disease-related research contexts: Cardiovascular-related experimental modelsRetinal ischemia and microvascular injury models Peripheral nerve injury and neuropathy models Small fiber nerve degeneration models Chronic inflammatory joint disease models Renal inflammation and metabolic stress models Hepatic lipid accumulation and inflammatory liver models Intestinal inflammation models Systemic autoimmune and immune dysregulation models Wound healing and tissue repair models 

ATN-161 is a synthetic pentapeptide used in preclinical research models to study integrin–extracellular matrix interactions, particularly those involving fibronectin binding. In in vitro systems and animal studies, modulation of these interactions has been employed to investigate cell adhesion, migration, angiogenesis-related signaling, and tissue remodeling mechanisms under experimental conditions.

B7-33 has been investigated in preclinical research models related to: Fibrotic tissue remodeling models Vascular protection and endothelial signaling models Cardiac injury and post-ischemic remodeling models Pulmonary inflammation and fibrosis-related models 

B7-33 has been investigated in preclinical research models related to: Fibrotic tissue remodeling models Vascular protection and endothelial signaling models Cardiac injury and post-ischemic remodeling models Pulmonary inflammation and fibrosis-related models  FRESHLY PREPARED SOLUTION 

Summary Bonomarlot, also known as Myelopeptide-2 (MP-2), is a synthetic hexapeptide derived from bone marrow peptides and studied for its immunomodulatory properties in experimental settings. It has demonstrated the ability to restore T-lymphocyte proliferation and normalize key surface markers such as CD3 and CD4 under conditions of immune suppression induced by tumor-derived factors. These effects suggest a role in supporting cellular signaling pathways involved in T-cell activation and functional recovery. Due to its small size and hydrophobic composition, MP-2 may interact efficiently with cellular membranes and protein interfaces, contributing to its biological activity. Current data are limited to preclinical research models, where MP-2 is used as a tool to investigate immune regulation, cellular recovery mechanisms, and tumor-associated immunosuppression.

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions. Thymosin Beta-4 is a 43-amino-acid peptide widely used in preclinical experimental systems to study actin-mediated cell migration, angiogenesis, inflammatory signaling, and tissue remodeling processes. In laboratory and animal models, Thymosin Beta-4 has been investigated for its role in wound-associated cell dynamics, oxidative stress responses, and regeneration-related signaling pathways. 

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions.

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions. Thymosin Beta-4 Fragment is a short peptide derived from the active region of Thymosin Beta-4, commonly employed in preclinical research to investigate actin-regulated cell migration, angiogenesis, inflammatory modulation, and tissue remodeling mechanisms. In experimental models, it has been studied for its involvement in wound-related cellular dynamics, oxidative stress responses, and regeneration-associated signaling pathways. FRESHLY PREPARED SOLUTION 

BPC-157 is a 15-amino-acid synthetic peptide used in preclinical research models to investigate cellular repair mechanisms, extracellular matrix dynamics, vascular signaling, and tissue stress responses. In in vitro systems and animal studies, BPC-157 has been explored for its involvement in pathways related to fibroblast activity, angiogenesis, nitric oxide-associated signaling, coagulation-related processes, immune modulation, and gene expression regulation under experimental conditions. FRESHLY PREPARED SOLUTION 

cAC-253 is a disulfide-cyclized research peptide used in preclinical experimental models to investigate amylin receptor–mediated signaling under conditions of amyloid-associated cellular stress. In in vitro systems and animal studies, cAC-253 has been explored for its effects on synaptic function, learning- and memory-related signaling pathways, amyloid-associated biochemical markers, and neuroinflammatory responses, providing a tool for mechanistic research into receptor-specific pathways involved in synaptic integrity.

cAC-253 is a disulfide-cyclized research peptide used in preclinical experimental models to investigate amylin receptor–mediated signaling under conditions of amyloid-associated cellular stress. In in vitro systems and animal studies, cAC-253 has been explored for its effects on synaptic function, learning- and memory-related signaling pathways, amyloid-associated biochemical markers, and neuroinflammatory responses, providing a tool for mechanistic research into receptor-specific pathways involved in synaptic integrity. FRESHLY PREPARED SOLUTION 

Cardiogen is a short synthetic peptide used in preclinical research models to study fibroblast-associated signaling and tissue remodeling mechanisms. In in vitro systems and animal studies, it has been investigated for its role in regulating cellular processes involved in extracellular matrix organization and scar-related responses under experimental conditions. FRESHLY PREPARED SOLUTION 

Cardiogen is a short synthetic peptide used in preclinical research models to study fibroblast-associated signaling and tissue remodeling mechanisms. In in vitro systems and animal studies, it has been investigated for its role in regulating cellular processes involved in extracellular matrix organization and scar-related responses under experimental conditions.

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa FRESHLY PREPARED SOLUTION 

Chonluten has been explored in relation to the regulation of pulmonary mucosa, gene networks involved in inflammatory and antioxidant processes, and tissue adaptation mechanisms across a broad range of acute and chronic respiratory and systemic stress conditions, of both infectious and non-infectious origin, including age-associated functional decline. Experimental findings indicate a predominant activity within pulmonary tissue, with secondary involvement observed in the gastrointestinal tract. Specifically, Chonluten has been studied in preclinical research contexts involving: post-infectious pulmonary recovery states chronic cardiopulmonary functional impairment persistent respiratory dysfunction recovery phases following prolonged mechanical ventilation long-term pulmonary adaptation after remission of granulomatous conditions acute respiratory distress and hypoxia-associated states high physiological load and exercise-related respiratory stress maintenance of respiratory function in ageing biological systems inflammation-driven pulmonary mucosal dysregulation inflammatory states and alterations of the gastrointestinal mucosa

CJC-1295 is a synthetic analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in growth hormone– and insulin-like growth factor 1 (IGF-1)–associated signaling pathways. Experimental studies have examined how incorporation of a Drug Affinity Complex (DAC) may extend the peptide’s plasma persistence, allowing prolonged observation of GH–IGF axis dynamics under controlled laboratory conditions. In preclinical experimental settings, CJC-1295 has been explored in relation to: – protein synthesis–associated anabolic signaling– lipid metabolism and body composition–related biochemical pathways

Modified GRF is a truncated peptide analogue of growth hormone–releasing hormone (GHRH) investigated in preclinical research for its involvement in GHRH-mediated signaling pathways. In experimental settings, Modified GRF has been explored in relation to: – muscle repair– and growth-associated cellular signaling – wound-associated tissue remodeling processes – bone metabolism and structural signaling pathways – lipid metabolism and fat-oxidation–related biochemical pathways – metabolic regulation–associated signaling networks – glucose homeostasis– and immune-related regulatory pathways

Colivelin is a humanin-family peptide that has been extensively investigated in preclinical research models for its involvement in neuronal stress-response pathways. Experimental studies conducted in vitro and in vivo indicate that Colivelin may influence mechanisms associated with amyloid-related aggregation processes, neuronal apoptosis, and synaptic plasticity regulation under neurodegenerative conditions.   

Colivelin is a humanin-family peptide that has been extensively investigated in preclinical research models for its involvement in neuronal stress-response pathways. Experimental studies conducted in vitro and in vivo indicate that Colivelin may influence mechanisms associated with amyloid-related aggregation processes, neuronal apoptosis, and synaptic plasticity regulation under neurodegenerative conditions.    FRESHLY PREPARED SOLUTION 

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models  FRESHLY PREPARED SOLUTION 

Cortagen has been investigated in preclinical and exploratory research settings for its potential involvement in brain reparative processes, cerebroprotective responses, and nootropic-like activity, within experimental models of cerebral stress and degeneration. Research literature has explored Cortagen in relation to the following neurobiological contexts: Cerebral lesion and injury models Neurodegenerative and dementing process models, including protein-aggregation and vascular-associated degeneration Extrapyramidal and movement-disorder research models Spinal and cerebellar system dysfunction models Central nervous system involvement in immune-mediated and inflammatory conditions Motor impairment and hemiplegia-related models Paralytic and neuromuscular dysfunction models Cerebral involvement in bacterial meningeal inflammation models Hemorrhagic cerebral stress models Transient and persistent cerebral ischemia models 

Research on Dihexa suggests it has been explored for its potential role in:Supporting neuronal repair mechanisms in experimental modelsPromoting synaptic connectivity and signaling pathways involved in neural plasticityEnhancing neurotrophic activity associated with growth-factor mediated communicationInvestigating protective effects in preclinical models of neurodegeneration, including Alzheimer’s- and Parkinson’s-related pathwaysSupporting cognitive performance parameters such as learning, memory formation, and recall in animal studiesImproving motivation- and mood-related behavioral markers in exploratory research modelsEnhancing mental endurance and sustained attention in cognitive testing paradigmsSupporting executive functions such as problem-solving and information processing speed in experimental settingsExploring effects on social recognition and interaction-related behavioral markers in preclinical studies

Research on Dihexa suggests it has been explored for its potential role in: Supporting neuronal repair mechanisms in experimental models Promoting synaptic connectivity and signaling pathways involved in neural plasticity Enhancing neurotrophic activity associated with growth-factor mediated communication Investigating protective effects in preclinical models of neurodegeneration, including Alzheimer’s- and Parkinson’s-related pathways Supporting cognitive performance parameters such as learning, memory formation, and recall in animal studies Improving motivation- and mood-related behavioral markers in exploratory research models Enhancing mental endurance and sustained attention in cognitive testing paradigms Supporting executive functions such as problem-solving and information processing speed in experimental settings Exploring effects on social recognition and interaction-related behavioral markers in preclinical studiesFRESHLY PREPARED SOLUTION

DNSP-11 is a short amidated peptide derived from the proGDNF domain that has been investigated in preclinical research models for its neurotrophic-like activity within dopaminergic systems. Experimental studies conducted in vitro and in vivo suggest that DNSP-11 may support dopaminergic neuron resilience, neuroadaptive responses, and neuronal survival mechanisms under conditions of neurodegenerative stress. DNSP-11 has been explored in research contexts related to: Dopaminergic neuron degeneration models Nigrostriatal system dysfunction Neuroprotective and neurorestorative pathways Modulation of dopamine and dopamine metabolite levels Motor asymmetry and behavioral outcome models Neuronal survival and anti-apoptotic signaling Neurite outgrowth and neuronal differentiation Toxin-induced neurodegeneration models FRESHLY PREPARED SOLUTION 

DNSP-11 is a short amidated peptide derived from the proGDNF domain that has been investigated in preclinical research models for its neurotrophic-like activity within dopaminergic systems. Experimental studies conducted in vitro and in vivo suggest that DNSP-11 may support dopaminergic neuron resilience, neuroadaptive responses, and neuronal survival mechanisms under conditions of neurodegenerative stress.DNSP-11 has been explored in research contexts related to:Dopaminergic neuron degeneration modelsNigrostriatal system dysfunctionNeuroprotective and neurorestorative pathwaysModulation of dopamine and dopamine metabolite levelsMotor asymmetry and behavioral outcome modelsNeuronal survival and anti-apoptotic signalingNeurite outgrowth and neuronal differentiationToxin-induced neurodegeneration models

DRP-104 is an experimental compound investigated for its ability to inhibit glutaminase 1 (GLS1), a key enzyme responsible for converting glutamine into glutamate. Because glutamate supports nucleotide synthesis, amino acid production, antioxidant defense, and mitochondrial energy metabolism, GLS1 inhibition can disrupt multiple metabolic pathways essential for tumor growth. Cancer cells frequently depend on glutamine metabolism to sustain rapid proliferation, energy generation, and redox homeostasis. By blocking GLS1, DRP-104 has been explored as a metabolic intervention that induces a state of metabolic stress in tumor cells, potentially reducing their proliferative capacity and promoting selective vulnerability. Research has also investigated DRP-104 for its broader implications in tumor biology, including potential effects on oxidative stress balance, growth signaling pathways such as mTOR, and tumor microenvironment nutrient competition. 

Delta sleep-inducing peptide (DSIP) is a neuropeptide that has been investigated in experimental and preclinical research settings for its involvement in the regulation of multiple endocrine and physiological processes, particularly those related to sleep–wake modulation and adaptive stress responses. Experimental studies suggest that DSIP may be associated with: Modulation of sleep-related physiological processes Regulation of sleep quality under conditions of chronic sleep disruption Adaptive responses to physiological and psychological stress Influence on autonomic and cardiovascular regulatory parameters Modulation of pain-related sensory processing FRESHLY PREPARED SOLUTION 

Delta sleep-inducing peptide (DSIP) is a neuropeptide that has been investigated in experimental and preclinical research settings for its involvement in the regulation of multiple endocrine and physiological processes, particularly those related to sleep–wake modulation and adaptive stress responses. Experimental studies suggest that DSIP may be associated with: Modulation of sleep-related physiological processes Regulation of sleep quality under conditions of chronic sleep disruption Adaptive responses to physiological and psychological stress Influence on autonomic and cardiovascular regulatory parameters Modulation of pain-related sensory processing

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health  

Epitalon stimulates the renewal of the whole body, beginning with the inside organs and working its way outward to the skin. It demonstrates a variety of bioactivities, including the following: Improving ocular retina condition in retinitis pigmentosa Anti-aging by activating chromatin in old age Anticancer and antitumour metastatic effects Activation telomerase Elongation of telomeres Survival of cells, resistance to stress and oxidative changes Balancing of endocrine secretion, improvement pineal gland function and increases the release of melatonin Decreased cortisol levels Increased antioxidant enzymes Increased brain health   FRESHLY PREPARED SOLUTION 

1 box/5 Pieces

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission    FRESHLY PREPARED SOLUTION 

FGL has been investigated in experimental and preclinical research settings for its role in supporting synapse formation between neurons, a process associated with synaptic plasticity and structural neuronal adaptation. Increased activity-dependent synaptic communication observed in research models suggests that FGL may contribute to information encoding mechanisms underlying learning and memory-related processes. According to experimental studies, FGL has been explored in relation to the following neurobiological contexts: Neuroprotective mechanisms in neuronal stress models Modulation of cognitive performance parameters in experimental systems Neural recovery and adaptation following traumatic brain injury models Protection against experimentally induced neurotoxic stress Memory-related processes in learning paradigms Learning-associated synaptic plasticity mechanisms Neurodegenerative and cognitive decline research models Modulation of neuroinflammatory signaling in central nervous system models Regulation of mood-related behavioral parameters in experimental settings Activity-dependent enhancement of excitatory synaptic transmission      

Follistatin-344 is a synthetic analogue of the naturally occurring follistatin protein. In preclinical and experimental research, it has been investigated for its interactions with signaling pathways involving myostatin, activins, and follicle-stimulating hormone (FSH). Findings from in vitro and animal studies suggest that modulation of these pathways may be associated with changes in cellular differentiation processes, tissue remodeling dynamics, and selected regulatory signaling mechanisms. These observations position Follistatin-344 as a molecule of interest in research contexts focused on tissue biology, regenerative signaling, and growth-regulatory pathways.

FOXO4-DRI is a research peptide investigated for its ability to selectively interact with cellular pathways associated with senescence. Preclinical studies suggest that modulation of senescent cell populations may support improvements in biological function and tissue-level homeostasis in experimental models of aging.  According to experimental and preclinical research observations, FOXO4-DRI has been associated with the following effects: Selective induction of apoptosis in senescent cells in laboratory models Improvement of physical performance parameters in aging animal studies Support of tissue and organ function markers in preclinical research Contribution to the restoration of tissue homeostasis under experimental conditions      

GcMAF Frag (Gc protein–derived macrophage activating factor fragment) is a peptide fragment derived from vitamin D–binding protein (DBP) and studied for its interaction with macrophages, key cells of the innate immune system involved in immune surveillance and phagocytic processes. In experimental and preclinical research settings, GcMAF Frag has been investigated for its ability to influence macrophage-associated signaling pathways and immune-related functional markers. Within controlled laboratory models, exposure to GcMAF-related fragments has been associated with modulation of macrophage activity, including phagocytosis-related assays and cytokine-associated readouts. For this reason, the peptide is primarily used as a research tool in studies focused on immune regulation, inflammatory signaling, and host defense mechanisms. Chemical modifications such as N-terminal acetylation and C-terminal amidation have been evaluated in peptide research for their impact on structural stability and resistance to enzymatic degradation. In experimental systems, these features may contribute to enhanced molecular stability, prolonged functional persistence, and optimized receptor interaction profiles under in vitro conditions.

GDF11 has been shown to improve the outcomes of neurodegenerative and neurovascular diseases, increase the amount of skeletal muscle and boost muscular strength. It also has the power to reverse age-related degenerative alterations, as well as govern organ and skin regeneration following damage. These are all examples of its biological effects, which include reversing senescence.

GDF-8 is involved in the regulation of myostatin activity, a key biological factor that normally limits muscle growth and regeneration. Experimental and preclinical research indicates that modulation of this pathway influences muscle and tissue dynamics associated with repair and adaptation. According to research-based observations, GDF-8 has been associated with the following effects: Enhancement of muscular regeneration and recovery processes following injury Support of the body’s regenerative capacity at the tissue level Increase in myofiber hypertrophy in experimental models

Organic Germanium GE-132 (carboxyethylgermanium sesquioxide) is a water-soluble organogermanium compound investigated for its effects on immune signaling, chemokine regulation, and oxidative stress pathways. Research consistently highlights modulation of the CCL2–CCR2 chemokine axis, which influences monocyte recruitment and macrophage trafficking, as well as induction of interferon-associated pathways with activation of NK cells and macrophages in experimental models. GE-132 has also been shown to suppress NF-κB and MAPK signaling and reduce inflammatory mediators under controlled conditions. Another key feature is redox modulation. Several studies report protection against hydrogen peroxide–induced oxidative stress, increased intracellular glutathione, reduced LDL oxidation, elevated α-tocopherol levels, and improved antioxidant enzyme activity. In vitro data also indicate increased cellular ATP levels and potential support of mitochondrial bioenergetics. Preclinical oncology research describes effects on tumor microenvironment regulation, macrophage M1 gene polarization, inhibition of the CCL2 pathway, and reduction of tumor progression. Additional experimental contexts include vascular inflammation, myocardial remodeling, neuroinflammatory paradigms, hepatic oxidative injury, antiviral immune signaling, and wound healing biology.

GHK with DAC is a modified form of the naturally occurring tripeptide GHK that has been engineered to enhance stability and prolong its persistence in experimental systems. Like native GHK, it has been widely investigated in laboratory and preclinical research for its involvement in multiple biological processes. Scientific studies suggest that GHK is associated with the following research-observed activities: Support of tissue repair processes Modulation of fibrinogen-related pathways Activation of DNA repair–related gene networks Engagement of the ubiquitin/proteasome system Influence on insulin and insulin-like signaling pathways. The addition of DAC (Drug Affinity Complex or stabilizing moiety) is designed to enhance resistance to enzymatic degradation and extend the duration of peptide activity in experimental conditions. This modification may allow for more sustained interaction with biological systems, supporting improved observation of time-dependent and cumulative effects in research models. Collectively, these properties make GHK with DAC a molecule of interest in research areas such as tissue regeneration, aging mechanisms, metabolic regulation, and cellular homeostasis, particularly in experimental settings where prolonged peptide exposure is required.

GHK is a naturally occurring tripeptide that has been widely investigated in experimental and laboratory research for its involvement in multiple biological processes. Scientific studies suggest that GHK is associated with the following research-observed activities: Support of tissue repair processes: Linked to collagen-related pathways and cellular mechanisms involved in wound repair and tissue maintenance. Modulation of fibrinogen-related pathways: Associated with inflammatory signaling regulation and vascular biology mechanisms in experimental models. Activation of DNA repair–related gene networks: Observed to influence pathways connected to genomic stability and cellular maintenance. Engagement of the ubiquitin/proteasome system: Studied for its role in supporting protein quality control and cellular homeostasis. Influence on insulin and insulin-like signaling pathways: Associated with metabolic regulation mechanisms in gene expression studies. Collectively, these properties make GHK a molecule of interest in research areas such as cardiovascular biology, aging mechanisms, metabolic regulation, and tissue regeneration. 

Made to Order Compound ✦ Price available upon request. For inquiries: contactus GHK-Cu with DAC is a modified version of the well-characterized copper tripeptide Gly-His-Lys (GHK), in which the peptide is conjugated with a stabilizing Maleimide-β-Ala linker designed to influence its persistence and interaction dynamics in experimental settings. Native GHK-Cu has been extensively studied for its involvement in tissue remodeling, extracellular matrix regulation, and cellular signaling processes. The addition of a DAC-type linker is intended to enhance the stability of the peptide and extend its functional presence in biological systems, allowing for more sustained interaction with target pathways under controlled research conditions. This modification does not alter the core peptide sequence but may influence how the compound behaves in terms of degradation resistance, distribution, and temporal activity profile. In laboratory and preclinical research, GHK-Cu has been associated with modulation of gene expression related to skin structure, cellular repair, inflammatory signaling, and oxidative balance. The DAC-conjugated form is therefore investigated as an extended-activity variant, suitable for studies requiring prolonged exposure and more stable peptide dynamics. All observations related to GHK-Cu and its modified forms derive from in vitro systems, animal studies, or other experimental models and are intended exclusively for scientific research purposes.

Made to Order Compound ✦ Price available upon request. For inquiries: contactus GHK-Cu with DAC is a modified version of the well-characterized copper tripeptide Gly-His-Lys (GHK), in which the peptide is conjugated with a stabilizing Maleimide-β-Ala linker designed to influence its persistence and interaction dynamics in experimental settings. Native GHK-Cu has been extensively studied for its involvement in tissue remodeling, extracellular matrix regulation, and cellular signaling processes. The addition of a DAC-type linker is intended to enhance the stability of the peptide and extend its functional presence in biological systems, allowing for more sustained interaction with target pathways under controlled research conditions. This modification does not alter the core peptide sequence but may influence how the compound behaves in terms of degradation resistance, distribution, and temporal activity profile. In laboratory and preclinical research, GHK-Cu has been associated with modulation of gene expression related to skin structure, cellular repair, inflammatory signaling, and oxidative balance. The DAC-conjugated form is therefore investigated as an extended-activity variant, suitable for studies requiring prolonged exposure and more stable peptide dynamics. All observations related to GHK-Cu and its modified forms derive from in vitro systems, animal studies, or other experimental models and are intended exclusively for scientific research purposes.

GHK-Cu is a naturally occurring copper-binding tripeptide widely studied for its role in tissue maintenance, cellular repair, and gene-regulatory processes. Research has associated GHK-Cu with multiple biological activities relevant to skin biology, cellular regeneration, and protective mechanisms at the molecular level. According to experimental and research observations, GHK-Cu has been associated with the following effects: Improves skin density and firmness Reduces the appearance of fine lines and deeper wrinkles Helps counteract photodamage related to environmental exposure Supports biological processes linked to hair follicle activity Demonstrates gene-regulatory activity relevant to cancer research models Supports mechanisms involved in nerve regeneration Activates pathways associated with DNA repair and cellular recovery All listed effects are derived from laboratory, preclinical, or controlled research contexts and are presented for scientific and educational purposes only.

The following is a list of some of the advantages of GHK-Cu: - Improve skin density and firmness - Reduce fine lines and deep wrinkles - Reduce photodamage - Hair growth benefit - Dna repairFRESHLY PREPARED SOLUTION

GHRP-2 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and pituitary-associated communication processes. Due to its targeted receptor activity, GHRP-2 remains a compound of interest in experimental models investigating signaling mechanisms related to growth hormone regulatory pathways and systemic endocrine coordination.

GHRP-6 is a synthetic hexapeptide classified as a growth hormone secretagogue and a selective agonist of the ghrelin receptor (GHS-R1a). It is studied in research contexts for its interaction with receptor-mediated signaling pathways involved in endocrine regulation and neuroendocrine communication processes. Due to its well-characterized receptor activity, GHRP-6 remains a compound of interest in experimental models investigating ghrelin-related signaling and growth hormone regulatory pathways.

Glyx-13 has been investigated in preclinical, experimental, and clinical research for its role in NMDA receptor modulation, synaptic plasticity, cognitive processing, and rapid antidepressant-associated neuroadaptive signaling. In particular, research has explored its relevance in: Rapid antidepressant response and reduction of depressive symptoms Treatment-resistant depression research contexts Synaptic plasticity and long-term potentiation (LTP) NMDA receptor modulation and glutamatergic signaling mTORC1-associated synaptic remodeling Dendritic spine formation and synaptic protein expression Cognitive function, attention, and memory-related processes Prefrontal cortical signaling and adaptive neuronal responsiveness Stress-related neural dysfunction Neurobiological mechanisms distinct from ketamine, including the absence of psychotomimetic and dissociative effects in research settings FRESHLY PREPARED SOLUTION 

HCG is a glycoprotein hormone studied in research contexts for its role in gonadotropin-related signaling pathways and endocrine regulatory mechanisms. It is associated with receptor-mediated processes involved in hormonal communication and system-wide endocrine coordination. Due to its well-characterized structure and role in endocrine signaling, HCG remains a key compound in experimental models investigating regulatory pathways of the hypothalamic–pituitary–gonadal axis.

HGH (191 AA) is a recombinant peptide hormone studied in research contexts for its role in endocrine signaling and systemic physiological regulation. It is associated with complex signaling pathways involved in cellular communication, metabolic coordination, and tissue-level regulatory processes. Due to its broad receptor distribution and multi-system activity, HGH remains a key subject of investigation in experimental models exploring integrative endocrine and metabolic mechanisms.